Intermittent Hypoxia 2: Cardiovascular and Metabolism

NCT02058823 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped budget constraints

Conditions

Hypoxia
Sleep Apnea
Obstructive Sleep Apnea

Interventions

DRUG: Placebo
DRUG: Placebo
DRUG: Valsartan
DRUG: Amlodipine

Sponsor

University Hospital, Grenoble

Collaborators

[object Object]